Skip to main content
. Author manuscript; available in PMC: 2023 Feb 9.
Published in final edited form as: J Med Chem. 2022 May 24;65(11):7656–7681. doi: 10.1021/acs.jmedchem.1c02171

Figure 4.

Figure 4.

Concentration–effect assessment of 16d against Spns2 and sphingosine kinases. S1P release decreased as a function of increased concentrations of 16d in Spn2-transfected Hela cells (A). Inhibition of recombinant mSphK1 (B) and mSphK2 (C) inhibition using a standard TLC-based assay. The assays were performed in duplicate.